News
The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide ...
On April 22, 2025, the US Food and Drug Administration (FDA) and the US Department of Health and Human Services (HHS) announced a plan to phase ...
3d
Vietnam Investment Review on MSNPharma sector faces up to AI hurdles
While AI and innovation are generating increasing spillover effects in the global pharmaceutical industry and improving ...
Supporters believe that FDA approval will make the drug more accessible. Right now, traditional psilocybin therapy offered at healing centers in the state is not covered by insurance.
At the centre of this are updates to Laboratory Information Management Systems (LIMS), repositories for laboratory data that ...
Under the terms of the agreement, Kowa receives exclusive rights to develop and commercialize NCX 470 in the US and all other ...
A woman is speaking out after her successful attempt to buy weight-loss drug Mounjaro by using a ‘before’ image of another ...
4d
Vietnam Investment Review on MSNIVD Medical Applies For US Stablecoin License
IVD Medical Holding Limited(01931.HK) - Forward-looking layout of the historical opportunity of the US "Genius Act", the IVDD stablecoin plan is gathering momentum to set sail and build a new global ...
Law Offices of Howard G. Smith reminds investors of the upcoming September 12, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Biohaven Ltd.
Complete Response Letters recently issued by the FDA signal heightened scrutiny of trial design and reinforce the agency’s shifting regulatory expectations for sponsors and CROs.
McNairy County Sheriff's Office seeks new full-time Deputy; candidates must be 18+, have a clean record, and pass physical ...
5d
Inquirer on MSNTrial of new dengue vaccine begins recruitment for child participants in Singapore
The new vaccine aims to provide protection against all four dengue serotypes. Read more at straitstimes.com. Read more at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results